Multinationals have recently been investing heavily in Israeli life science companies. They include Boston Scientific into MValve (heart valves), Novartis into Gamida Cell (stem cell therapies) and eHealthVentures into Intendu (brain dysfunction treatment).
Global demand for Israeli health tech
This entry was posted in Economy & Business. Bookmark the permalink.